stella
beta
Assessment of AI Program 'DRISTi' as a Screening Tool — Stella
Home
/
Diabetic Retinopathy (DR)
/
Assessment of AI Program 'DRISTi' as a Screening Tool
View on ClinicalTrials.gov
Recruiting
Back to Diabetic Retinopathy (DR) trials
Assessment of AI Program 'DRISTi' as a Screening Tool
Trial locations
(2 sites)
United States
New Century Ophthalmology - Oxford, Oxford, North Carolina
New Century Ophthalmology - Raleigh, Raleigh, North Carolina